Short answer
Ginkgo Bioworks Holdings, Inc. (DNA) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Ginkgo divesting its entire Biosecurity segment (Ginkgo Biosecurity, LLC) to Tower Biosecurity, Inc.: a full operational separation, not a partial sale.
Ginkgo Bioworks Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Ginkgo divesting its entire Biosecurity segment (Ginkgo Biosecurity, LLC) to Tower Biosecurity, Inc.: a full operational separation, not a partial sale
- Deal structure: no cash received; Ginkgo takes ~20% equity stake in Tower Biosecurity on a fully diluted basis
- Non-cash consideration signals Biosecurity segment had limited standalone sale value; Ginkgo retains upside only via minority stake
- Expected close H1 2026, subject to customary conditions: no regulatory hurdles specifically cited
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ginkgo Bioworks Holdings, Inc. 8-K filings
Get the next DNA 8-K as it lands
Follow DNA for push alerts, or ask the research agent what this filing means.